Coronavirus disease (COVID-19) Pandemic

Languages

Service navigation

Search

Coronavirus disease (COVID-19) Pandemic

Empfehlung des Bundesrates: Bleiben Sie zu Hause, insbesondere, wenn Sie alt oder krank sind

Information on the current situation in Switzerland

Information for health professionnals, FAQs, recommendations for travellers.

 
Official information page

Product information

Comirnaty® - Information for healthcare professionals (in German)

Comirnaty® - Patient information (in German)

COVID-19 Vaccine Janssen - Information for healthcare professionals (in German)

COVID-19 Vaccine Janssen - Patient information (in German)

COVID-19 Vaccine Moderna - Information for healthcare professionals (in German)

COVID-19-mRNA-Impfstoff (Nukleosid-modifiziert)

COVID-19 Vaccine Moderna - Patient information (in German) (PDF, 72 kB, 22.01.2021)

ZL000_00_044e_WL Guidance document Authorisation procedures for Covid-19 medicinal products during a pandemic (PDF, 284 kB, 15.05.2021)

Questions and answers on the packaging and labelling requirements for medicinal products intended to prevent or combat COVID-19 (PDF, 125 kB, 22.12.2020)

FOPH - Coronavirus: häufig gestellte Fragen (FAQ)

(www.bag.admin.ch)

All about the vaccines - briefly and concisely explained

Vaccines: Rapid solution for new diseases?

Swismedic - The way a vaccination works

How an mRNA vaccine works

How a vector vaccine works?

How a protein vaccine works

How is the safety of vaccines monitored?

Communication regarding COVID-19

28.07.2021

Out-of-Stock – COVID-19 – Authorisations for the temporary import and distribution of human medicines – Update

Licences in accordance with art. 22 para. 3 of the COVID 19 Ordinance 3

23.07.2021

Reports of suspected adverse reactions to COVID-19 vaccines in Switzerland – update

4,319 reports evaluated – the overall positive benefit-risk ratio of the vaccines remains

02.07.2021

Reports of suspected adverse reactions to COVID-19 vaccines in Switzerland – update

3,419 reports evaluated – the overall positive benefit-risk ratio of the vaccines remains

28.06.2021

COVID-19 rapid self-tests: validation and dispensing

The Federal Office of Public Health (FOPH) checks the validation of COVID-19 rapid self-tests (also known as SARS-CoV-2 self-tests)

18.06.2021

Reports of suspected adverse reactions to COVID-19 vaccines in Switzerland – update

2,944 reports evaluated – the overall positive benefit-risk ratio of the vaccines remains

11.06.2021

COVID-19 vaccine for young people aged 12 to 17: Moderna submits authorisation application to Swissmedic

Another indication extension under rolling review

10.06.2021

Empfehlung bezüglich COVID-19 für die autologe Blutstammzellspende

Beschluss Vorschriften SBSC – Blutstammzellspende

04.06.2021

Side effects of COVID-19 vaccines in Switzerland – update

2,701 reports of suspected adverse reactions to COVID-19 vaccines in Switzerland evaluated

04.06.2021

Pfizer/BioNTech COVID-19 vaccine approved for young people in Switzerland

Swissmedic approves indication extension for Comirnaty® for 12 to 15-year-olds

04.06.2021

Investigation of reports of myocarditis in connection with COVID-19 mRNA vaccines

Information for healthcare professionals
https://www.swissmedic.ch/content/swissmedic/en/home/news/coronavirus-covid-19.html